Elif Bilgin
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Cells and Metastasis
Papers in
- Oncology 20
- Cancer Cells and Metastasis 5
- Peptidase Inhibition and Analysis 4
- Pancreatic and Hepatic Oncology Research 4
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Derya Duranyıldız (20 shared papers)Faruk Taş (17 shared papers)Kayhan Ertürk (13 shared papers)Didem Taştekin (10 shared papers)Senem Karabulut (14 shared papers)Vildan Yasasever (7 shared papers)Murat Serilmez (4 shared papers)Leyla Kılıç (5 shared papers)
In The Last Decade
Elif Bilgin
33 papers receiving 309 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 85
- Oncology 124
- Internal Medicine 16
- Immunology and Allergy 20
- Immunology 53
Countries citing papers authored by Elif Bilgin
This map shows the geographic impact of Elif Bilgin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elif Bilgin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elif Bilgin more than expected).
Fields of papers citing papers by Elif Bilgin
This network shows the impact of papers produced by Elif Bilgin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elif Bilgin. The network helps show where Elif Bilgin may publish in the future.
Co-authors
The 25 scholars most cited alongside Elif Bilgin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 25 | |
| 2 | 2016 | 23 | |
| 3 | 2014 | 19 | |
| 4 | 2017 | 19 | |
| 5 | 2014 | 18 | |
| 6 | 2015 | 16 | |
| 7 | 2012 | 15 | |
| 8 | 2014 | 13 | |
| 9 | 2013 | 12 | |
| 10 | 2017 | 11 | |
| 11 | 2014 | 11 | |
| 12 | 2015 | 11 | |
| 13 | 2015 | 11 | |
| 14 | 2016 | 9 | |
| 15 | 2012 | 8 | |
| 16 | Clinical significance of serum interleukin-17 levels in colorectal cancer patients. | 2017 | 7 |
| 17 | 2013 | 7 | |
| 18 | 2016 | 7 | |
| 19 | 2013 | 7 | |
| 20 | 2019 | 7 |
About Elif Bilgin
Elif Bilgin is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 33 papers that have together received 310 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (6 papers), Cancer Cells and Metastasis (5 papers), Protease and Inhibitor Mechanisms (5 papers), Peptidase Inhibition and Analysis (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Cellular Mechanics and Interactions (3 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Cancer Research (85 citations), Oncology (124 citations), Internal Medicine (16 citations), Immunology and Allergy (20 citations) and Immunology (53 citations). Elif Bilgin has collaborated with scholars based in Türkiye and Germany. Frequent co-authors include Derya Duranyıldız, Faruk Taş, Kayhan Ertürk, Didem Taştekin, Senem Karabulut, Vildan Yasasever, Murat Serilmez, Leyla Kılıç, Faruk Taş and Rümeysa Çiftçi. Their work appears in journals such as Tumor Biology, Melanoma Research, Biomedical Reports, Biomedicine & Pharmacotherapy and Biomolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.